Article
Sentinel surveillance of the WHO-validated Pfkelch13 C580Y artemisinin resistance marker in Plasmodium falciparum isolates from Bangui, Central African Republic
2026-05-04
Abstract excerpt
<title>Abstract</title> <p>Background Artemisinin-based combination therapies (ACTs) are the cornerstone of malaria treatment. However, partial artemisinin resistance associated with mutations in the Plasmodium falciparum kelch13 (pfk13) propeller domain threatens malaria control efforts. The C580Y substitution is the principal World Health Organization (WHO) validated molecular marker for resistance surveillanc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bfad8cf3-f5a0-5d65-88db-c7a6c766084c
- DOI
- 10.21203/rs.3.rs-9399260/v1
